Cargando…
Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study
BACKGROUND: Combined hepatocellular and cholangiocarcinoma (CHC) is a unique subtype of liver cancer comprising both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC); however, its cellular origin remains unclear. The purpose of this study was to investigate the clinicopatholo...
Autores principales: | Zhao, Qian, Yu, Wen-Long, Lu, Xin-Yuan, Dong, Hui, Gu, Yi-Jin, Sheng, Xia, Cong, Wen-Ming, Wu, Meng-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995671/ https://www.ncbi.nlm.nih.gov/pubmed/27552844 http://dx.doi.org/10.1186/s40880-016-0146-7 |
Ejemplares similares
-
Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism
por: Meola, Giovanni, et al.
Publicado: (2015) -
Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD
por: Yadegari, Hamideh, et al.
Publicado: (2022) -
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021) -
The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies
por: Becherucci, Valentina, et al.
Publicado: (2023) -
Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)